HARROW HEALTH, INC. Stock Agreements
10 Contracts & Agreements
- IMPRIMISPHARMACEUTICALS, INC. 2017INCENTIVE STOCK AND AWARDS PLAN NOTICEOF Restricted Stock Unit AWARD (Filed With SEC on June 16, 2017)
- IMPRIMISPHARMACEUTICALS, INC. 2017INCENTIVE STOCK AND AWARDS PLAN NOTICEOF RESTRICTED STOCK AWARD (Filed With SEC on June 16, 2017)
- IMPRIMISPHARMACEUTICALS, INC. 2017INCENTIVE STOCK AND AWARD PLAN FORMOF NONQUALIFIEDSTOCK OPTION AGREEMENT (Filed With SEC on June 16, 2017)
- IMPRIMISPHARMACEUTICALS, INC. 2017INCENTIVE STOCK AND AWARDS PLAN INCENTIVESTOCK OPTION AGREEMENT (Filed With SEC on June 16, 2017)
- IMPRIMISPHARMACEUTICALS, inc. 2,900,000 SHARESOF COMMON STOCK UNDERWRITINGAGREEMENT (Filed With SEC on March 11, 2016)
- ImprimisPharmaceuticals, Inc. Sharesof Common Stock (parvalue $0.001 per share) ControlledEquity OfferingSM SalesAgreement (Filed With SEC on November 27, 2015)
- WARRANTTO PURCHASE STOCK (Filed With SEC on May 12, 2015)
- Stock Purchase Agreement, dated as of August 30, 2012, by and between Imprimis Pharmaceuticals, Inc. and Professional Compounding Centers of America, Inc (Filed With SEC on August 31, 2012)
- IMPRIMIS PHARMACEUTICALS, INC. NOTICE OF STAND-ALONE RESTRICTED STOCK UNIT AWARD Grantees Name and Address:Robert J. Kammer (Filed With SEC on July 25, 2012)
- IMPRIMIS PHARMACEUTICALS, INC. NOTICE OF STAND-ALONE RESTRICTED STOCK UNIT AWARD (Filed With SEC on July 25, 2012)
